2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?

Modern use of post-operative radioactive iodine (RAI) treatment for differentiated thyroid cancer (DTC) should be implemented in line with patient s’ risk stratification. Although beneficial effects of radioiodine are undisputed in high -risk patients, controversy remains in intermediate-risk and so...

Full description

Bibliographic Details
Main Authors: Furio Pacini, Dagmar Fuhrer, Rossella Elisei, Daria Handkiewicz-Junak, Sophie Leboulleux, Markus Luster, Martin Schlumberger, Johannes W Smit
Format: Article
Language:English
Published: Bioscientifica 2023-01-01
Series:European Thyroid Journal
Subjects:
Online Access:https://etj.bioscientifica.com/view/journals/etj/11/1/ETJ-21-0046.xml
_version_ 1797955321715490816
author Furio Pacini
Dagmar Fuhrer
Rossella Elisei
Daria Handkiewicz-Junak
Sophie Leboulleux
Markus Luster
Martin Schlumberger
Johannes W Smit
author_facet Furio Pacini
Dagmar Fuhrer
Rossella Elisei
Daria Handkiewicz-Junak
Sophie Leboulleux
Markus Luster
Martin Schlumberger
Johannes W Smit
author_sort Furio Pacini
collection DOAJ
description Modern use of post-operative radioactive iodine (RAI) treatment for differentiated thyroid cancer (DTC) should be implemented in line with patient s’ risk stratification. Although beneficial effects of radioiodine are undisputed in high -risk patients, controversy remains in intermediate-risk and some low-risk pati ents. Since the last consensus on post-surgical use of RAI in DTC patients, new retr ospective data and results of prospective randomized trials have been published, w hich have allowed the development of a new European Thyroid Association (ETA) stateme nt for the indications of post-surgical RAI therapy in DTC. Questions about which pati ents are candidates for RAI therapy, which activities of RAI can be used, and which mod alities of pre-treatment patient preparation should be used are addressed in the present guidelines.
first_indexed 2024-04-10T23:32:21Z
format Article
id doaj.art-f5bc1da3cd3245e8a6fee2a1cab6f5da
institution Directory Open Access Journal
issn 2235-0802
language English
last_indexed 2024-04-10T23:32:21Z
publishDate 2023-01-01
publisher Bioscientifica
record_format Article
series European Thyroid Journal
spelling doaj.art-f5bc1da3cd3245e8a6fee2a1cab6f5da2023-01-12T05:46:01ZengBioscientificaEuropean Thyroid Journal2235-08022023-01-0111119https://doi.org/10.1530/ETJ-21-00462022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?Furio Pacini0Dagmar Fuhrer1Rossella Elisei2Daria Handkiewicz-Junak3Sophie Leboulleux4Markus Luster5Martin Schlumberger6Johannes W Smit7Section of Endocrinology, University of Siena, Siena, ItalyDepartment of Endocrinology, Diabetes and Metabolism, West German Cancer Centre (WTZ), University Hospital Essen, University Duisburg-Essen, Essen, GermanySection of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyDepartment of Nuclear Medicine and Endocrine Oncology, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, PolandGustave Roussy Cancer Campus and University Paris-Saclay, Villejuif, Cedex, FranceDepartment of Nuclear Medicine, University Hospital Marburg, Marburg, GermanyGustave Roussy Cancer Campus and University Paris-Saclay, Villejuif, Cedex, FranceRadboud University Medical Center, Nijmegen, NetherlandsModern use of post-operative radioactive iodine (RAI) treatment for differentiated thyroid cancer (DTC) should be implemented in line with patient s’ risk stratification. Although beneficial effects of radioiodine are undisputed in high -risk patients, controversy remains in intermediate-risk and some low-risk pati ents. Since the last consensus on post-surgical use of RAI in DTC patients, new retr ospective data and results of prospective randomized trials have been published, w hich have allowed the development of a new European Thyroid Association (ETA) stateme nt for the indications of post-surgical RAI therapy in DTC. Questions about which pati ents are candidates for RAI therapy, which activities of RAI can be used, and which mod alities of pre-treatment patient preparation should be used are addressed in the present guidelines.https://etj.bioscientifica.com/view/journals/etj/11/1/ETJ-21-0046.xmldifferentiated thyroid cancerradioiodinetreatmentindications
spellingShingle Furio Pacini
Dagmar Fuhrer
Rossella Elisei
Daria Handkiewicz-Junak
Sophie Leboulleux
Markus Luster
Martin Schlumberger
Johannes W Smit
2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?
European Thyroid Journal
differentiated thyroid cancer
radioiodine
treatment
indications
title 2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?
title_full 2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?
title_fullStr 2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?
title_full_unstemmed 2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?
title_short 2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?
title_sort 2022 eta consensus statement what are the indications for post surgical radioiodine therapy in differentiated thyroid cancer
topic differentiated thyroid cancer
radioiodine
treatment
indications
url https://etj.bioscientifica.com/view/journals/etj/11/1/ETJ-21-0046.xml
work_keys_str_mv AT furiopacini 2022etaconsensusstatementwhataretheindicationsforpostsurgicalradioiodinetherapyindifferentiatedthyroidcancer
AT dagmarfuhrer 2022etaconsensusstatementwhataretheindicationsforpostsurgicalradioiodinetherapyindifferentiatedthyroidcancer
AT rossellaelisei 2022etaconsensusstatementwhataretheindicationsforpostsurgicalradioiodinetherapyindifferentiatedthyroidcancer
AT dariahandkiewiczjunak 2022etaconsensusstatementwhataretheindicationsforpostsurgicalradioiodinetherapyindifferentiatedthyroidcancer
AT sophieleboulleux 2022etaconsensusstatementwhataretheindicationsforpostsurgicalradioiodinetherapyindifferentiatedthyroidcancer
AT markusluster 2022etaconsensusstatementwhataretheindicationsforpostsurgicalradioiodinetherapyindifferentiatedthyroidcancer
AT martinschlumberger 2022etaconsensusstatementwhataretheindicationsforpostsurgicalradioiodinetherapyindifferentiatedthyroidcancer
AT johanneswsmit 2022etaconsensusstatementwhataretheindicationsforpostsurgicalradioiodinetherapyindifferentiatedthyroidcancer